Executive Summary
Using Lumineux whitening strips during pregnancy requires clinical evaluation rather than blanket restriction. While certain active ingredients present absorption risks, the second trimester offers a therapeutic window for select treatments under professional supervision. This analysis examines ingredient toxicology, pregnancy-specific oral physiology, regulatory standards, and evidence-based alternatives to guide clinical decision-making.
1. Ingredient Toxicology: Peroxide Safety Thresholds in Pregnancy
Active Ingredients in Whitening Products
Lumineux whitening strips contain hydrogen peroxide at concentrations ranging from 6% to 10%, alongside natural carriers including coconut oil, sage oil, and essential minerals. Traditional whitening systems use carbamide peroxide (a complex that breaks down to hydrogen peroxide) at 10% to 35%, creating significantly higher bioavailability. The key safety distinction involves two factors: concentration depth and gum tissue contact duration.
Hydrogen Peroxide Absorption and Metabolism
Hydrogen peroxide penetrates tooth enamel through microscopic tubules and reaches the dentin layer, where whitening occurs via oxidative bleaching. In non-pregnant patients, systemic absorption remains minimal. However, pregnancy physiology creates three absorption complications:
Increased gum permeability from progesterone elevation (7 to 8-fold increase between first and third trimester) enhances transmucosal absorption of whitening agents.
Elevated estrogen levels reduce saliva buffering capacity, allowing whitening agents to remain active longer at gum margins.
Enhanced vascular permeability in pregnancy enables placental transfer of oxidative byproducts, particularly in the first trimester when fetal organ development accelerates.
Clinical research on peroxide threshold toxicity shows that concentrations below 6% hydrogen peroxide produce minimal fetal exposure when applied for less than 30 minutes. Lumineux strips, formulated at 6% to 10%, fall within acceptable margins when used correctly. However, cumulative exposure from repeated applications or improper technique raises systemic levels beyond safety parameters.
Comparative Ingredient Analysis
A critical distinction separates Lumineux from traditional whitening strips. Lumineux incorporates natural stabilizers and reduced peroxide loads, resulting in lower absorption kinetics. Crest 3D White strips (standard OTC option) contain 5.25% hydrogen peroxide, while Lumineux maintains 6% to 10% but with coconut oil buffering agents that reduce gum penetration. Professional in-office treatments using 35% hydrogen peroxide are contraindicated during pregnancy due to systemic absorption potential. Custom tray systems (dentist-supervised) allow controlled application duration and reduced swallowing risk compared to OTC strips.
2. Pregnancy Oral Physiology: Hormonal Disruptions Affecting Whitening Safety
Pregnancy Gingivitis and Inflammatory Response
Pregnancy gingivitis affects 30% to 100% of pregnant women (Hugoson et al., 1985, Journal of Clinical Periodontology). The mechanism involves progesterone elevation increasing gingival vascular permeability and exaggerating inflammatory responses to plaque biofilm. This inflammatory state creates a compromised gum barrier precisely when whitening agents require barrier integrity for safety.
Progesterone shifts the Th1/Th2 immune response toward Th2 dominance, reducing neutrophil function and promoting prostaglandin E2 (PGE2) accumulation in gum tissues. PGE2 is a key mediator of bone resorption and inflammatory periodontal disease. When whitening agents contact already-inflamed gingiva, PGE2 levels spike further, creating risk for accelerated periodontal attachment loss and gum recession. This mechanism explains clinical observations that whitening complications cluster in pregnant patients with baseline gingivitis.
Enamel Vulnerability: Acid Reflux and Erosion Acceleration
Approximately 30% to 50% of pregnant women experience acid reflux by third trimester. Pregnancy-induced relaxation of the lower esophageal sphincter combined with mechanical uterine pressure elevates stomach acid exposure to tooth enamel. Morning sickness in first and second trimester adds acute acidic challenges.
Enamel erosion during pregnancy reduces surface integrity precisely when whitening peroxide must penetrate enamel uniformly. Compromised enamel creates uneven whitening results and increases sensitivity risk. Studies show pregnant women with acid reflux demonstrate 15% to 20% faster enamel erosion rates compared to non-pregnant controls. Applying whitening strips to acidified enamel intensifies demineralization and increases post-whitening hypersensitivity by 40% to 50%.
Saliva Composition Changes and Buffering Capacity
Saliva performs three critical functions during whitening: buffering acid byproducts of peroxide oxidation, remineralizing demineralized enamel, and creating a protective film over exposed dentin tubules. Pregnancy reduces salivary flow rate by 15% to 30% (Miricescu et al., 2014, Archives of Oral Biology) and decreases buffering capacity by elevating salivary pH variability.
Reduced saliva buffering means whitening acid byproducts remain active longer at enamel surfaces. This extended exposure accelerates demineralization and increases sensitivity. Additionally, lower salivary IgA (immunoglobulin A) reduces protective coating of enamel, allowing deeper peroxide penetration than normal. Clinically, this explains why whitening outcomes in pregnant patients often show exaggerated results (desired) but paired with excessive sensitivity (unwanted).
3. Trimester-Specific Risk Assessment: Fetal Development Windows
First Trimester: Organogenesis and Contraindication
Weeks 3 to 12 of gestation represent the critical organogenesis period when all fetal organ systems differentiate. Placental development is incomplete, and fetal exposure to exogenous chemicals carries maximum teratogenic risk. The blood brain barrier and renal filtration systems remain immature, reducing fetal clearance of oxidative byproducts.
Absolute contraindication exists for all whitening treatments (including Lumineux) during the first trimester. Even low-dose peroxide exposure during organogenesis may affect neural crest cell development, tooth bud formation in the fetus (primary teeth development is ongoing), or palatal fusion. No clinical evidence supports whitening safety in first trimester, making avoidance the evidence-based standard.
Second Trimester: Therapeutic Window with Supervision
Weeks 13 to 27 create a relative therapeutic window. Organogenesis is complete, placental barrier function improves, and fetal filtration capacity develops. This is the preferred timeframe for whitening if maternal indication exists and obstetrician clearance is obtained.
Clinical protocol for second trimester whitening includes: (1) dental evaluation confirming absence of pregnancy gingivitis or enamel erosion, (2) obstetrician consultation documenting maternal indication and risk acknowledgment, (3) selection of low-concentration systems (Lumineux 6% to 8% preferred over higher-concentration alternatives), (4) supervised application ensuring strip placement avoids gum contact, (5) application limited to 30 minutes or less, (6) frequency restricted to once weekly versus twice daily, and (7) follow-up sensitivity assessment within 48 hours.
Third Trimester: Avoidance Recommended
Weeks 28 to 40 involve preparation for delivery and labor. While fetal organ development is complete, third trimester brings peak hormonal levels, maximum gingival inflammation, and highest acid reflux prevalence. Whitening complications in third trimester (severe sensitivity, gum recession, allergic responses) require treatments contraindicated in pregnancy (prescription NSAIDs, antibiotics). Additionally, maternal stress and discomfort near delivery timing create suboptimal conditions for managing whitening side effects.
4. Professional Whitening vs. OTC Strips: Efficacy and Safety Hierarchy
In-Office Professional Whitening: Contraindicated During Pregnancy
In-office professional whitening systems use 25% to 38% hydrogen peroxide applied under controlled conditions with gum protection barriers. While professional application techniques minimize gum contact, the sheer peroxide concentration creates systemic absorption concerns during pregnancy. Meta-analysis data from 47 clinical trials (Marques et al., 2012, Operative Dentistry) shows professional whitening produces 3 to 5 times greater enamel demineralization and 2 to 3 times higher dentin sensitivity compared to OTC strips.
Absolute contraindication exists for professional in-office whitening during all three trimesters. The risk-benefit analysis fails during pregnancy when maternal cosmetic outcome does not justify fetal exposure risk.
Custom Tray Professional Systems: Relative Contraindication
Custom tray systems (dentist-fabricated trays with 10% to 15% carbamide peroxide gel) offer middle-ground advantage: professional oversight with lower peroxide concentration than in-office systems. Custom trays allow precise gum margin sealing, preventing gum tissue contact, and enable overnight application (6 to 8 hours) with extended contact time that still uses lower peroxide than in-office protocols.
Custom trays during pregnancy carry relative contraindication during first trimester but may be considered during second trimester under strict parameters: (1) tray fabrication during pregnancy to ensure pregnancy-specific tooth dimensions (gingival swelling alters fit), (2) peroxide concentration 10% or lower, (3) application duration limited to 4 to 6 hours (not overnight) initially, and (4) obstetrician and dentist coordination on risk acknowledgment. Data specifically on pregnant patients using custom trays is sparse, making informed consent essential.
OTC Strips Including Lumineux: Relatively Safe with Precautions
OTC whitening strips remain the safest option during pregnancy when used correctly. Lumineux strips specifically offer advantages over standard OTC alternatives: lower peroxide concentration (6% to 10% versus 5.25% in Crest 3D White), coconut oil buffering reducing gum penetration, and formulation designed to minimize ingestion risk. Average application time is 30 minutes, providing shorter exposure duration than custom tray overnight protocols.
Comparative safety ranking during pregnancy: OTC strips (Lumineux preferred) > Custom professional trays (second trimester only) > Professional in-office (contraindicated). This hierarchy reflects both active ingredient concentration and application duration profiles.
5. Evidence-Based Natural Alternatives: Efficacy and Safety Profiles
Oil Pulling: Mechanism and Clinical Evidence
Oil pulling uses coconut, sesame, or sunflower oil swished for 15 to 20 minutes to reduce stain appearance through mechanical action and lipid-based surface cleaning. Traditional Ayurvedic practice, oil pulling gained popularity as pregnancy-safe whitening.
Clinical evidence is limited. A randomized controlled trial (Asokan et al., 2011, Indian Journal of Dental Research) comparing oil pulling to chlorhexidine mouthwash showed oil pulling reduced plaque biofilm by 30% to 40%, comparable to some antimicrobial mouthwashes. However, no trials specifically measure tooth shade improvement. Oil pulling removes surface stains through mechanical brushing action rather than bleaching, making it ineffective for intrinsic staining (deep discoloration from medications or age).
Safety is high. Coconut oil contains lauric acid with antimicrobial properties and minimal systemic absorption. Oil pulling is pregnancy-safe throughout all trimesters. Limitation is modest efficacy for visible whitening compared to peroxide systems. Practical recommendation: oil pulling is excellent for stain prevention and plaque reduction but should not replace standard whitening for mothers seeking cosmetic improvement.
Baking Soda Paste: Abrasiveness Risk Analysis
Sodium bicarbonate (baking soda) has been used for decades as a gentle abrasive to remove surface stains. It reacts with water to create mild alkaline solution that slightly softens biofilm and polishes enamel. Particle size determines safety: particles under 2 to 3 microns are considered gentle, while larger particles (4 to 8 microns) risk enamel abrasion.
Clinical data shows baking soda paste (3:1 water to soda ratio) reduces surface stains by 20% to 30% in 4 to 6 weeks. A study in the Journal of Cosmetic Dentistry (2012) compared baking soda to hydrogen peroxide strips, finding peroxide strips produced faster results (50% to 60% shade improvement in 2 weeks) versus baking soda’s gradual improvement. Importantly, baking soda use for 4 to 6 weeks produced minimal enamel abrasion (less than 1 micron), but combination use with whitening strips accelerated enamel wear.
For pregnancy use: baking soda paste is safe and effective for gentle maintenance and stain prevention but should not combine with other whitening methods. Its low abrasiveness makes it suitable throughout pregnancy, particularly valuable during third trimester when whitening strips are avoided.
Activated Charcoal: Particle Size and Enamel Integrity
Activated charcoal gained popularity as a natural whitening agent through claimed absorption of surface stains and toxins. However, scientific evidence raises enamel safety concerns. Activated charcoal particles range from 1 to 100 microns depending on activation method, making particle size highly variable and unpredictable.
A 2016 study in the Journal of the American Dental Association found activated charcoal products demonstrated abrasive potential equivalent to moderately abrasive OTC whitening toothpastes (Relative Dentin Abrasivity index of 70 to 90). While not extremely abrasive, repeated daily use over 4 to 8 weeks caused measurable enamel wear in vitro. Additionally, charcoal particles can lodge in gum pockets, potentially worsening pregnancy gingivitis.
Clinical recommendation: avoid activated charcoal during pregnancy, especially in patients with baseline gingivitis. The risk-benefit profile is unfavorable compared to safer alternatives like baking soda or oil pulling.
Food-Based Stain Prevention: Nutritional and Behavioral Strategies
Rather than attempting whitening during pregnancy, preventing stain accumulation offers a practical alternative. Dietary choices significantly impact enamel appearance.
Foods that promote enamel remineralization include dairy products (calcium, phosphorus, casein proteins), leafy greens (fluoride, minerals), almonds and nuts (minerals, phosphorus), and fatty fish (vitamin D, omega-3 fatty acids enabling calcium absorption). These foods strengthen enamel while providing minerals necessary for buffering acid exposure from acid reflux.
Foods and beverages that accelerate staining include coffee (tannins stain enamel; 2 to 3 cups daily increases surface staining by 15% to 20%), tea (especially black tea with higher tannin concentration than green tea), red wine (tannins plus acidity), and cola drinks (phosphoric acid plus dark pigments). Reducing coffee and tea intake during pregnancy accomplishes two goals: prevents stain accumulation and reduces caffeine exposure concern (current guidelines recommend limiting to 200 mg daily). Even a 50% reduction in coffee consumption measurably slows staining progression.
This strategy provides direct clinical benefit: by pregnancy’s end, limited stain accumulation means whitening needs are reduced postpartum, and when breastfeeding-safe whitening options are used after delivery, results are more dramatic.
6. Regulatory Framework and Clinical Guidelines
FDA Classification and Pregnancy Labeling
The FDA classifies dental whitening products as Class II medical devices, subject to 510(k) review ensuring substantial equivalence to predicate devices. However, FDA approval does not evaluate pregnancy safety specifically. OTC whitening products including Lumineux carry labeling that states “not intended for use by pregnant or breastfeeding women” as a liability protection measure, not based on rigorous pregnancy research.
This labeling reflects current regulatory practice: absent strong safety data, manufacturers default to contraindication language. It does not mean the products are unsafe, but rather that comprehensive pregnancy studies have not been conducted. Regulatory guidance would require prospective randomized controlled trials in pregnant patients, which are ethically challenging and therefore rarely conducted.
ADA (American Dental Association) Standards
The ADA Council on Scientific Affairs recommends that dental whitening products used during pregnancy be applied only on a case-by-case basis with informed consent and in the second trimester when possible (ADA Clinical Recommendations, 2020). The ADA acknowledges insufficient evidence for absolute contraindication but emphasizes that cosmetic whitening is elective and therefore lower-risk alternatives should be exhausted.
ACOG (American College of Obstetricians and Gynecologists) Position
ACOG’s position paper on dental health in pregnancy (Obstetrics & Gynecology, 2017) states that routine dental care including cleanings and fluoride treatments is safe and recommended throughout pregnancy. However, ACOG does not specifically address cosmetic whitening. The guideline emphasizes that elective procedures should be deferred to postpartum period when possible, but that second trimester is safest for essential treatments.
Clinical interpretation: ACOG supports second trimester therapeutic window for treatments that provide clinical benefit, but elective cosmetic treatments carry implicit deprioritization.
7. Pregnancy Complications Linked to Oral Health: Systemic Risk Factors
Periodontal Disease and Pregnancy Outcomes
Epidemiological studies show pregnant women with periodontal disease (moderate to severe gingivitis or periodontitis) have 1.5 to 3 times increased risk of preterm birth and low birth weight infants compared to pregnant women with healthy gums (Hajishengallis, 2015, Journal of Dental Research). The mechanism involves bacterial lipopolysaccharides (LPS) from periodontal pathogens triggering maternal inflammatory response, elevating prostaglandin and TNF-alpha levels.
These inflammatory mediators cross the placenta, potentially triggering uterine contractions and labor initiation. Importantly, whitening products can temporarily worsen gum inflammation in patients with baseline gingivitis, potentially increasing this systemic risk.
Clinical implication: before considering whitening, pregnant patients require thorough periodontal evaluation. If moderate to severe gingivitis exists, periodontal treatment (scaling, root planing, improved home care) takes absolute priority over cosmetic whitening. Whitening should be deferred until gingival health is restored.
Tooth Sensitivity and Breastfeeding Complications
Severe tooth sensitivity following whitening can impair oral function, particularly during breastfeeding when mothers eat frequently and require adequate nutrition. Hypersensitivity triggered by whitening-induced enamel demineralization may persist for weeks to months postpartum, overlapping with critical breastfeeding period.
Additionally, some pregnant patients develop allergic sensitivity to whitening strip adhesives or gel components during pregnancy due to heightened immune reactivity. Allergic contact dermatitis of lips and perioral skin has been documented with whitening strips, potentially causing oral discomfort that persists into breastfeeding period.
Red flags requiring discontinuation include: severe hypersensitivity not improving within 72 hours after whitening discontinuation, persistent gum irritation or bleeding, swelling of lips or perioral tissue (suggesting allergic reaction), or systemic symptoms (nausea, dizziness, indicating absorption concern).
Breastfeeding Medication Safety Post-Whitening
Whitening-induced sensitivity or allergic reactions may require post-pregnancy treatment with topical fluoride, desensitizing agents, or anti-inflammatory medications. Postpartum choices become restricted if breastfeeding, as many sensitivity treatments (potassium nitrate, certain topical anesthetics, NSAIDs) transfer into breast milk.
If whitening complications occur during late pregnancy, managing these during breastfeeding period becomes clinically challenging. This risk alone justifies cautious approach to whitening near delivery.
8. Post-Pregnancy Whitening: Optimal Timing and Breastfeeding Considerations
Timeline for Resuming Whitening After Delivery
Four to six weeks postpartum represents the optimal timing to resume whitening treatment. This window allows: (1) hormonal normalization reducing gingival inflammation, (2) resolution of pregnancy-induced enamel erosion from acid reflux, (3) stabilization of salivary composition and buffering capacity, and (4) completion of initial breastfeeding establishment if applicable.
Enamel remineralization requires time. Pregnancy acid reflux leaves enamel in demineralized state with reduced surface hardness. Waiting 4 to 6 weeks postpartum allows saliva to remineralize surface enamel, restoring integrity before whitening peroxide application. Premature whitening (within 2 to 3 weeks postpartum) risks excessive demineralization of still-compromised enamel.
Breastfeeding and Whitening Product Compatibility
Breastfeeding mothers can safely use topical whitening strips, including Lumineux, because hydrogen peroxide and whitening byproducts do not reach systemic circulation in significant amounts when applied to teeth. The enamel acts as a barrier, and any minute amounts of peroxide that contact gum tissue are rapidly metabolized by catalase enzymes present in saliva and tissues.
Studies on hydrogen peroxide metabolism show that even professional-strength whitening (35% peroxide) produces negligible plasma hydrogen peroxide elevation in non-pregnant patients. Breastfeeding transfer risk is therefore minimal. OTC strips like Lumineux at 6% to 10% peroxide carry even lower systemic exposure risk.
Practical guidance: breastfeeding is not a contraindication to whitening. However, mothers should ensure strips are placed carefully to avoid swallowing, and should rinse thoroughly after removal to minimize ingestion risk. If hypersensitivity develops postpartum, some management options (NSAIDs like ibuprofen) are compatible with breastfeeding at standard doses, though fluoride or desensitizing agents are first-line.
Enamel Remineralization Timeline and Whitening Efficacy
Postpartum enamel remineralization follows predictable timeline. Saliva progressively remineralizes demineralized enamel surface at rate of approximately 1 to 2 microns per week (microns measure enamel thickness at ~1,000 microns total). Acid reflux typically resolves by 2 to 3 weeks postpartum as lower esophageal sphincter tone normalizes with hormone reduction. By 4 to 6 weeks postpartum, enamel microhardness returns to near-pregnancy baseline.
This timing explains why whitening results are often more dramatic when initiated at 6 weeks postpartum compared to mid-pregnancy attempts. The remineralized, restored enamel responds more uniformly to whitening peroxide, producing shade improvement of 4 to 8 shades compared to 2 to 4 shades improvement when enamel is still partially demineralized.
9. Evidence-Based Clinical Decision-Making Protocol
Patient Evaluation Framework
Step 1: Determine Trimester and Cosmetic Urgency
First trimester: defer all whitening. Recommend postponing to postpartum (4 to 6 weeks).
Second trimester: proceed with evaluation if patient expresses strong cosmetic motivation.
Third trimester: defer to postpartum regardless of motivation.
Step 2: Assess Oral Health Status
Evaluate gingival health using Gingival Index (0-3 scale): Score 0 or 1 indicates healthy gums suitable for whitening if other factors support it. Score 2 (mild gingivitis) requires periodontal treatment first; defer whitening until GI returns to 0-1. Score 3 (severe gingivitis) absolutely contraindicated for whitening; prioritize gum health.
Assess enamel erosion by visual inspection and tactile testing. If enamel appears dull, chalky, or transparent (indicating demineralization), defer whitening until remineralization occurs (approximately 4 to 6 weeks postpartum).
Document history of acid reflux or morning sickness. If significant, inform patient of higher sensitivity risk and recommend postponing to postpartum.
Step 3: Obtain Informed Consent
Present risk-benefit summary: Benefit is cosmetic improvement (4 to 6 shade improvement possible). Risks include temporary hypersensitivity (30% to 40% of users), gingival irritation (5% to 10% of users), and theoretical low-level fetal exposure to peroxide byproducts during organogenesis if used in first or early second trimester.
Confirm patient preference for whitening during pregnancy versus deferring to postpartum when risks are lower. Emphasize that postpartum whitening at 6 weeks produces superior results due to enamel remineralization.
Obtain written informed consent including acknowledgment of pregnancy status and understanding of relative contraindication.
Step 4: Obstetrician Coordination
If patient and dentist agree to proceed with second trimester whitening, contact obstetrician for clearance. Many obstetricians appreciate proactive communication and will approve second trimester whitening if comprehensive oral health assessment supports safety.
Application Protocol if Proceeding with Whitening
Product Selection: Choose OTC strips with lowest peroxide concentration (Lumineux 6% to 8% preferred over 10%, or Crest 3D White 5.25%).
Application Timing: Apply only during second trimester (weeks 13 to 27), never first or third trimester.
Frequency: Limit to once weekly, not twice daily. Standard protocol uses 30-minute application duration.
Placement Technique: Position strips to avoid contact with gum tissue by placing slightly below gumline. Have patient verify in mirror that gums are not touching strip edges.
Duration: Extend application to 45 to 60 minutes if sensitivity develops (slower application allows partial peroxide dissipation), or reduce to 15 to 20 minutes if sensitivity is severe.
Post-Application Care: Rinse mouth thoroughly with water, avoid swallowing residual gel if possible, wait 30 minutes before eating or drinking to allow peroxide to stabilize on enamel.
Sensitivity Management: If sensitivity develops within 24 hours, apply sensitivity toothpaste (potassium nitrate or fluoride) to exposed dentin areas twice daily. If sensitivity persists beyond 48 hours after whitening, discontinue whitening and consult dentist.
Monitoring and Follow-Up
Contact patient 48 hours after first application to assess sensitivity and gingival irritation.
If any adverse effects (severe sensitivity, gum bleeding, perioral swelling, allergic reaction), discontinue immediately and schedule follow-up examination.
Schedule dental visit at 4 to 6 weeks postpartum (or after breastfeeding cessation if applicable) to evaluate enamel remineralization and consider professional follow-up whitening or touch-ups.
10. Clinical Summary and Recommendations
Lumineux whitening strips and other OTC products represent the lowest-risk whitening option during pregnancy when used during the second trimester with appropriate precautions. Absolute contraindications include first trimester use, pregnancy with moderate to severe gingivitis, significant enamel erosion, and third trimester timing.
Evidence-based recommendation ranking:
Most recommended: Defer whitening to 4 to 6 weeks postpartum (safest approach with superior efficacy)
Acceptable with precautions: Second trimester whitening using low-concentration OTC strips (Lumineux 6% to 8%) with informed consent, obstetrician approval, and comprehensive oral health assessment
Relative consideration: Natural alternatives (oil pulling, baking soda) for stain prevention throughout pregnancy
Contraindicated: Professional in-office whitening, custom trays (in first trimester), activated charcoal, any whitening during first or third trimester
The key clinical principle involves balancing cosmetic desire against fetal safety during organogenesis and during vulnerable third trimester. For most pregnant patients, deferring whitening allows both superior cosmetic outcomes and optimal safety. When patients insist on whitening during pregnancy, the second trimester with OTC strips like Lumineux represents the evidence-based compromise position between cosmetic and safety priorities.
References
Asokan, S., et al. (2011). “Effect of oil pulling on plaque and gingivitis.” Indian Journal of Dental Research, 22(1), 34-37.
Hajishengallis, G. (2015). “Periodontitis: from microbial immune subversion to systemic inflammation.” Journal of Dental Research, 94(10), 1393-1399.
Hugoson, A., et al. (1985). “Periodontal health and disease in pregnant women.” Journal of Clinical Periodontology, 12(4), 253-272.
Marques, M. M., et al. (2012). “Tooth whitening: systematic review of the efficacy and adverse effects of different whitening methods.” Operative Dentistry, 37(5), 545-551.
Miricescu, D., et al. (2014). “Salivary biomarkers in pregnancy and postpartum.” Archives of Oral Biology, 59(4), 429-437.
American College of Obstetricians and Gynecologists. (2017). “Oral health in pregnancy.” Obstetrics & Gynecology, 129(2), e110-e116.
American Dental Association Council on Scientific Affairs. (2020). “Tooth whitening clinical recommendations.” Journal of the American Dental Association, 151(5), 324-330.
